Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining -0.13% today. In the last week its performance is 1.91%, and -0.03% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 243.83, so today’s gain of -0.13% is a significant step towards its target price. The GAP today is therefore 0.22%.
CR Bard Inc. (NYSE:BCR), has a market cap of 16270, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 90.50%.
At the current price of 221.21, it has a dividend yield of 0.47%, and its target price is 243.83. This is with a profit margin of 9.10%, and total debt/equity of 1.01. CR Bard Inc. (NYSE:BCR) has a P/E of 43.69, as well as a forward P/E of 19.58.
With a current EPS of 5.06, and a forecasted EPS growth for next year at 11.14%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.87%.
Performance for the year is 16.76%. Since its IPO date on 4/6/1983, the total performance to date is 17.19%.
Volume today for CR Bard Inc. (NYSE:BCR), is 228400, while its average volume is 437.31. Whilst the total gain today was -0.13%, it did have a day high of -7.51%.
Volatility for this week has been at 1.19%, and 1.09% for the month. The 52-week low for CR Bard Inc., BCR has been 28.92%, while the 52-week-high has reached -7.51%.
Looking at its return of investments, which is 6.40%, and its return on assets is 6.30%. CR Bard Inc. (NYSE:BCR) has an operating margin of 14.10%. With a sales growth of -44.50% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 1.01, and has a current ratio of 2.4 and 1.9 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 4.02, and the P/S is 4.59, along with a P/B of 10.06. Meanwhile it has a p/cash of 20.39.